Brazil reforms clinical research regulatory framework to improve competitiveness

Brazil has implemented new legislation to streamline clinical trial approvals, addressing long-standing bureaucratic hurdles that previously diverted pharmaceutical investment to other markets. The shift aims to leverage the country's genetic diversity and medical infrastructure to regain its position as a global hub for clinical research.